CymitQuimica logo

CAS 1000998-59-3

:

BMS-687453

Description:
BMS-687453, with the CAS number 1000998-59-3, is a chemical compound that has been studied primarily for its potential therapeutic applications, particularly in the field of oncology. It is classified as a small molecule inhibitor, specifically targeting certain pathways involved in cancer cell proliferation and survival. The compound exhibits selective inhibition of specific kinases, which are enzymes that play critical roles in various cellular processes, including signal transduction and cell division. BMS-687453 has shown promise in preclinical studies, demonstrating efficacy against certain cancer types by disrupting the signaling pathways that promote tumor growth. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are essential for determining its suitability for clinical use. Additionally, ongoing research aims to elucidate its safety profile and potential side effects, which are crucial for evaluating its therapeutic index. Overall, BMS-687453 represents a significant area of interest in drug development aimed at improving cancer treatment outcomes.
Formula:C22H21ClN2O6
Synonyms:
  • CS-1533
  • N-[[3-[[2-(4-Chlorophenyl)-5-methyl-4-oxazolyl]methoxy]phenyl]methyl]-N-(methoxycarbonyl)glycine
  • 2-[[3-[[2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methoxy]phenyl]methyl-methoxycarbonylamino]acetic acid
  • BMS-687453
  • Glycine, N-[[3-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methoxy]phenyl]methyl]-N-(methoxycarbonyl)-
  • BMS-687453;BMS687453;BMS 687453
  • N-(3-{[2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}benzyl)-N-(methoxycarbonyl)glycine
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
  • Glycine, N-[[3-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methoxy]phenyl]methyl]-N-(methoxycarbonyl)-

    CAS:
    Formula:C22H21ClN2O6
    Purity:98%
    Color and Shape:Solid
    Molecular weight:444.8649

    Ref: IN-DA0000WV

    1mg
    55.00€
    5mg
    71.00€
    10mg
    117.00€
    25mg
    117.00€
    50mg
    195.00€
    100mg
    235.00€
    250mg
    530.00€
  • N-(3-((2-(4-Chlorophenyl)-5-Methyloxazol-4-Yl)Methoxy)Benzyl)-N-(Methoxycarbonyl)Glycine

    CAS:
    <p>N-(3-((2-(4-Chlorophenyl)-5-Methyloxazol-4-Yl)Methoxy)Benzyl)-N-(Methoxycarbonyl)Glycine</p>
    Purity:98%
    Molecular weight:444.87g/mol

    Ref: 54-OR1024347

    1g
    942.00€
    100mg
    220.00€
    250mg
    352.00€
  • BMS-687453

    CAS:
    <p>BMS-687453</p>
    Purity:≥98%
    Molecular weight:444.86g/mol

    Ref: 54-BUP04924

    2mg
    87.00€
    5mg
    135.00€
    10mg
    211.00€
    25mg
    402.00€
    50mg
    604.00€
    100mg
    886.00€
  • BMS-687453

    CAS:
    <p>BMS-687453 is a potent and selective PPAR alpha agonist, with an EC(50) of 10 nM for human PPARalpha and approximately 410-fold selectivity vs human PPARgamma</p>
    Formula:C22H21ClN2O6
    Purity:99.4%
    Color and Shape:Solid
    Molecular weight:444.86
  • BMS-687453

    CAS:
    <p>BMS-687453 is an amide compound that inhibits the activity of creatine kinase and targets the expression of genes involved in lipid metabolism. It has been shown to be effective in treating type 2 diabetes by lowering blood sugar levels. BMS-687453 also reduces serum urea nitrogen and phenylpropionic acid, which are metabolites of amino acids. BMS-687453 can activate low-density lipoprotein cholesterol, thereby reducing the risk of atherosclerosis. It is also an inhibitor of diabetic neuropathy and it has been shown to reduce pain perception in animal models. The mechanism by which BMS-687453 reduces pain may be due to its ability to inhibit the production and release of inflammatory cytokines such as TNF-α and IL-1β through activation of nuclear hormone receptors.</p>
    Formula:C22H21ClN2O6
    Purity:Min. 95%
    Molecular weight:444.86 g/mol

    Ref: 3D-AQB99859

    25mg
    871.00€
    50mg
    1,143.00€
    100mg
    1,828.00€